Making Patients the Priority in 2020

In this ISSUE

Market Access: Employers as Barriers to Value

Making Sense of Copay Accumulators

Back to the Basics?

Opinion

Is Pharma Losing the Centerpiece of Its Market Access Toolbox?

With employers and the public scrutinizing drug prices like never before, rebates—long at the center of pharma’s market access strategy—may be losing their luster, writes Amber Gilbert.
... /Read more/

Market Pricing Dynamics for the Machine Learning Age Are You Getting the Insights You Need?
Thursday, March 26, 2019 at 11am EDT |10am CDT |4pm BST |5pm CEST

Digital Pharma

Beyond “Tech Talent”: New Leadership in Pharma’s Digital Age

With an increase in digital technology being utilized as a strategic differentiator and business enabler in pharma, where is talent coming from?
... /Read more/

Break Free from Forecast Inaccuracy: How Machine Learning Can Drive Better Quality Commercial Forecasting
Thursday, February 20, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Market Access

Lundbeck's Taj Bhardwaj: Market Access and Mental Health

Lundbeck's Taj Bhardwaj talks about leading both local and global-level market access strategies in pharma—and how his current company is committed to the fight to advance new treatments and break down stigmas in mental health.
... /Read more/

Calendar

/ Pharmapack Drug Delivery & Packaging — 2/5-2/6 /

/ Compliance Monitoring, Audit & Risk Oversight — 2/10-2/12 /

/ Life Sciences Compliance Congress Asia — 2/27-2/28 /

/ 16th Life Sciences Accounting & Reporting Congress — 3/16-3/19 /

Benchmark Your Clinical Development Plans and Drive Better Clinical Strategy
Thursday, January 30, 2020 at 11am EST | 10am PST | 4pm GMT | 5pm CET

Executive Profile

Unprecedented Times for Market Access: Amy Mahery

Amy Mahery, last month appointed Global Head of Market Access and Pricing of the healthcare business of Merck KGaA, Darmstadt, Germany, discusses her key priorities and how she will draw on her multi-faceted industry experience to approach the challenges ahead.
... /Read more/

The Pharm Exec Podcast: Episode 46

Sponsored by Fingerpaint

Persistence and Planning Pays Off

Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the road. She discusses the value of focusing on strengths and how that is currently working for Millendo in the endocrine space.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com